TABLE 2.
Changes in anthropometrics in response to CLI.
| Baseline | 10 weeks | 1.5 years | ||
|---|---|---|---|---|
| N | n (%)/Mean (±SEM)/Median (IQR) | n (%)/Mean (±SEM)/Median (IQR) | n (%)/Mean (±SEM)/Median (IQR) | |
| Female (%) | 39 | 31 (79.5%) | ||
| Age (years) | 39 | 41.8 (±2.1) | ||
| Type 2 Diabetes (%) | 39 | 9 (23.1%) | 8 (20.5%) | 8 (20.5%) |
| BMI (kg/m2) | 39 | 40.6 (±0.9) | 38.5 (±0.9)*** | 38.5 (±0.9)*** |
| WC (cm) | 39 | 115.4 (±2.4) | 108.6 (±2.4)*** | 109.3 (±2.6)*** |
| Weight (kg) | 39 | 118.6 (±3.1) | 112.6 (±2.9)*** | 112.6 (±3.1)*** |
| Triglycerides (mmol/l) | 39 | 1.27 (0.89–1.76) | 1.02 (0.88–1.55) | 1.10 (0.82–1.52) |
| HDL | 39 | 1.22 (1.02–1.51) | 1.18 (0.96–1.37)* | 1.33 (1.18–1.45)$$$ |
| LDL | 39 | 3.24 (±0.15) | 2.98 (±0.13)* | 3.14 (±0.16) |
| Hba1c (mmol/l) | 39 | 38 (±0.6) | 37 (±0.6)** | 37 (±0.6)* |
| Blood glucose (mmol/l) | 39 | 5.6 (5.2–6.5) | 5.2 (4.9–5.9)* | 5.5 (5.1–6.2) $ |
| HOMA-IR | 37 | 5.03 (3.23–7.90) | 4.19 (2.55–5.16)** | 4.32 (2.52–5.84)* |
BMI = body-mass-index, WC = waist circumference; HDL = high-density lipoprotein; LDL = low-density lipoprotein; HOMA-IR = Homeostatic Model Assessment for Insulin Resistance. ***p < .001, **p < .01, *p < .05 indicates significant difference compared to baseline; $ $ $ p < .001, $ p < .05 indicates significant difference compared to 10 weeks. Tested using Bonferroni-corrected repeated-measurements ANOVA.